The researcher Marta Pardo from the UV gets a grant from the Alicia Koplowitz Foundation

Marta Pardo, researcher Ramon y Cajal from the Department of Psychobiology from the UV and member of theInteruniversity Research Institute for Molecular Recognition and Technological Development (IDM), has been awarded with one of the grants to the research projects in the XX Call 2024 from the Alicia Koplowitz Foundation. The distinction recognizes the excellence in the scientific research in Child Psychiatry, neuropsychiatrist disorders and neuroscience.

The Koplowitz grants push forward innovative researches that look for the improvement of the life-quality of the people affected by neuropshichiatric pathologies. This financial support not only reinforces the development of pioneer projects, but also consolidates the reputation of the researchers and the institutions that embrace it.

Marta Pardo’s project, titled ’Impacto del Estrés Temprano en la Adolescencia: Un Modelo Translacional Innovador para Estudiar los Efectos del Ejercicio y la Vía Glutamatérgica en Individuos Genéticamente Vulnerables’, deals with a fundamental problem for the public health: the effect of early stress in the development of psychiatric disorders like anxiety, depression and post traumatic stress disorder (PTSD).

The research will take place in collaboration with Laura López-Cruz, from the Open University (United Kingdom), and Mercé Correa, from the Universitat Jaume I of Castellón, both experienced in stress models and animal behaviour. The student Silvia Giménez also makes up part of
Marta Pardo, researcher Ramón y Cajal from the Universitat de València and graduated in Psychology, completed her doctorate in the Universitat Jaume I (UJI) from Castellón with a pre-doctoral scholarship.The last 11 years, she has worked in the University of Miami (EEUU), in different scientific posts, in which stands out the Brain Endowment Bank, Department of Psychiatry, Department of Neurology and Department of Molecular and Cellular Pharmacology. As she worked in many fields, including depression, the addiction to morphine, the addiction to drugs, etc., she developed her two main lines of research.The first line is the use of transgenic DAT rats for disorders related to stress.The second, the magnetoelectric nanoparticles (MENPs) for psychiatric treatments. In 2024, she received the Ramón y Cajal award and moved her laboratory to the Universitat de València.